DB23041InvestigationalProtein Based Therapies
Procizumab is under investigation in clinical trial NCT06331884 (Phase 1 Study to Evaluate Safety, Tolerability and Pharmacokinetics/-Dynamics of AK1967 (Procizumab)).
- Mechanism
- Curator reviewed
Pharmacologically active on Dipeptidyl peptidase 3
- Code names
- AK1967
Resolves to
Compound
Targets
What you can answer from here — as of June 27, 2026
Which drugs share a target with Procizumab, and which of those have an active Phase 3 trial?
Create a free account or log in to explore the full data card.
Create Account